AD-LEARN Course on Nuclear Medicine in Biomarker-Based Diagnosis of Neurocognitive Disorders

Why AD-LEARN?

Neurocognitive disorders like Alzheimer’s Disease are on the rise—yet many professionals still face challenges in applying biomarker-based diagnostics effectively and consistently.
AD-LEARN is your go-to platform for mastering the latest in nuclear medicine imaging for the diagnosis and follow-up of cognitive disorders. Learn at your pace, connect with experts, and bring clarity to complexity.

What You'll Learn

How to evaluate cognitive complaints and differentiate syndromes

When and how to use functional imaging (FDG-PET, SPECT, amyloid PET)

How to interpret brain scans in typical and atypical Alzheimer’s

The latest recommendations on biomarkers and diagnostic pathways

How to communicate with and care for patients with MCI or dementia during scans

What's Inside

Mini-courses for Residents, Technologists and Nurses Focused primers to get you started or sharpen your current skills.

10 Self-paced Online Modules Each module includes expert lectures, real clinical cases, and interactive quizzes.

Hands-on Training
Final onsite course with practical sessions and direct guidance from specialists

CME-Accredited
Earn certification as you learn and apply your skills in your professional development

Who It's For

Nuclear medicine physicians and residents
Technologists, radiographers, nurses
Neurologists, psychiatrists, referring clinicians
Researchers in cognitive and neurodegenerative disorders

Whether you’re new to brain imaging or seeking to refine your diagnostic approach—this course is for you.

Timeline at a Glance

May 2025:
Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders? (Access Now)
Mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders (Acess Now)

September 2025 - July 2026:
Release of monthly online modules

November 2026:
Final onsite course

Get Started!

Join a growing network of professionals improving diagnostic pathways for patients with neurocognitive disorders.
Sign up now and take the first step toward clearer imaging, better care, and more confident clinical decisions.

SIgn Up!

Sponsored by an educational grant by Eli-Lilly